PMC:1064873 / 7035-8202 JSON TXT

Annnotations TAB JSON ListView MergeView

LappsTest

{"project":"LappsTest","denotations":[{"id":"T6554","span":{"begin":788,"end":791},"obj":"Protein"},{"id":"T6553","span":{"begin":600,"end":603},"obj":"Protein"},{"id":"T6552","span":{"begin":566,"end":569},"obj":"Protein"},{"id":"T6551","span":{"begin":540,"end":564},"obj":"Protein"}],"text":"Patients and samples\nThe total patient population consisted of 32 patients with RA (25 women and seven men; mean ± standard deviation age, 52.8 ± 12.4 years) diagnosed according to the revised 1987 criteria of the American College of Rheumatology (formally, the American Rheumatism Association) [25]. All patients were receiving prednisolone (≤ 7.5 mg/day) and disease-modifying antirheumatic drugs. Clinical parameters in the study patients were as follows (mean ± standard deviation): erythrocyte sedimentation rate, 55.9 ± 35.4 mm/hour; serum C-reactive protein (CRP) level, 32.0 ± 32.0 mg/l; and IgM class rheumatoid factor titer, 142 ± 158 U/ml. Patients were divided into two groups: 24 patients with active disease, who had multiple tender and/or swollen joints and elevated serum CRP level (≥ 10 mg/l); and eight patients with inactive disease, who satisfied the American College of Rheumatology preliminary criteria for clinical remission [26]. Sixteen healthy volunteers (11 women and five men; age, 45.8 ± 11.2 years) served as controls. ST samples were obtained from three RA patients undergoing total knee replacement. All patients gave informed consent."}

2_test

{"project":"2_test","denotations":[{"id":"15535835-3358796-4156884","span":{"begin":296,"end":298},"obj":"3358796"},{"id":"15535835-7306232-4156885","span":{"begin":949,"end":951},"obj":"7306232"}],"text":"Patients and samples\nThe total patient population consisted of 32 patients with RA (25 women and seven men; mean ± standard deviation age, 52.8 ± 12.4 years) diagnosed according to the revised 1987 criteria of the American College of Rheumatology (formally, the American Rheumatism Association) [25]. All patients were receiving prednisolone (≤ 7.5 mg/day) and disease-modifying antirheumatic drugs. Clinical parameters in the study patients were as follows (mean ± standard deviation): erythrocyte sedimentation rate, 55.9 ± 35.4 mm/hour; serum C-reactive protein (CRP) level, 32.0 ± 32.0 mg/l; and IgM class rheumatoid factor titer, 142 ± 158 U/ml. Patients were divided into two groups: 24 patients with active disease, who had multiple tender and/or swollen joints and elevated serum CRP level (≥ 10 mg/l); and eight patients with inactive disease, who satisfied the American College of Rheumatology preliminary criteria for clinical remission [26]. Sixteen healthy volunteers (11 women and five men; age, 45.8 ± 11.2 years) served as controls. ST samples were obtained from three RA patients undergoing total knee replacement. All patients gave informed consent."}

biosemtest

pmc-enju-pas

UBERON-AE

{"project":"UBERON-AE","denotations":[{"id":"T6557","span":{"begin":1114,"end":1118},"obj":"http://purl.obolibrary.org/obo/UBERON_0001465"},{"id":"T6556","span":{"begin":782,"end":787},"obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"T6555","span":{"begin":540,"end":545},"obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Patients and samples\nThe total patient population consisted of 32 patients with RA (25 women and seven men; mean ± standard deviation age, 52.8 ± 12.4 years) diagnosed according to the revised 1987 criteria of the American College of Rheumatology (formally, the American Rheumatism Association) [25]. All patients were receiving prednisolone (≤ 7.5 mg/day) and disease-modifying antirheumatic drugs. Clinical parameters in the study patients were as follows (mean ± standard deviation): erythrocyte sedimentation rate, 55.9 ± 35.4 mm/hour; serum C-reactive protein (CRP) level, 32.0 ± 32.0 mg/l; and IgM class rheumatoid factor titer, 142 ± 158 U/ml. Patients were divided into two groups: 24 patients with active disease, who had multiple tender and/or swollen joints and elevated serum CRP level (≥ 10 mg/l); and eight patients with inactive disease, who satisfied the American College of Rheumatology preliminary criteria for clinical remission [26]. Sixteen healthy volunteers (11 women and five men; age, 45.8 ± 11.2 years) served as controls. ST samples were obtained from three RA patients undergoing total knee replacement. All patients gave informed consent."}

GO-BP

{"project":"GO-BP","denotations":[{"id":"T6866","span":{"begin":1005,"end":1008},"obj":"http://purl.obolibrary.org/obo/GO_0007568"},{"id":"T6865","span":{"begin":134,"end":137},"obj":"http://purl.obolibrary.org/obo/GO_0007568"}],"text":"Patients and samples\nThe total patient population consisted of 32 patients with RA (25 women and seven men; mean ± standard deviation age, 52.8 ± 12.4 years) diagnosed according to the revised 1987 criteria of the American College of Rheumatology (formally, the American Rheumatism Association) [25]. All patients were receiving prednisolone (≤ 7.5 mg/day) and disease-modifying antirheumatic drugs. Clinical parameters in the study patients were as follows (mean ± standard deviation): erythrocyte sedimentation rate, 55.9 ± 35.4 mm/hour; serum C-reactive protein (CRP) level, 32.0 ± 32.0 mg/l; and IgM class rheumatoid factor titer, 142 ± 158 U/ml. Patients were divided into two groups: 24 patients with active disease, who had multiple tender and/or swollen joints and elevated serum CRP level (≥ 10 mg/l); and eight patients with inactive disease, who satisfied the American College of Rheumatology preliminary criteria for clinical remission [26]. Sixteen healthy volunteers (11 women and five men; age, 45.8 ± 11.2 years) served as controls. ST samples were obtained from three RA patients undergoing total knee replacement. All patients gave informed consent."}

sentences

{"project":"sentences","denotations":[{"id":"T6864","span":{"begin":1132,"end":1167},"obj":"Sentence"},{"id":"T6863","span":{"begin":1049,"end":1131},"obj":"Sentence"},{"id":"T6862","span":{"begin":954,"end":1048},"obj":"Sentence"},{"id":"T6861","span":{"begin":690,"end":953},"obj":"Sentence"},{"id":"T6860","span":{"begin":651,"end":689},"obj":"Sentence"},{"id":"T6859","span":{"begin":400,"end":650},"obj":"Sentence"},{"id":"T6858","span":{"begin":301,"end":399},"obj":"Sentence"},{"id":"T6857","span":{"begin":21,"end":300},"obj":"Sentence"},{"id":"T6856","span":{"begin":0,"end":20},"obj":"Sentence"},{"id":"T37","span":{"begin":0,"end":20},"obj":"Sentence"},{"id":"T38","span":{"begin":21,"end":300},"obj":"Sentence"},{"id":"T39","span":{"begin":301,"end":399},"obj":"Sentence"},{"id":"T40","span":{"begin":400,"end":650},"obj":"Sentence"},{"id":"T41","span":{"begin":651,"end":689},"obj":"Sentence"},{"id":"T42","span":{"begin":690,"end":953},"obj":"Sentence"},{"id":"T43","span":{"begin":954,"end":1048},"obj":"Sentence"},{"id":"T44","span":{"begin":1049,"end":1131},"obj":"Sentence"},{"id":"T45","span":{"begin":1132,"end":1167},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Patients and samples\nThe total patient population consisted of 32 patients with RA (25 women and seven men; mean ± standard deviation age, 52.8 ± 12.4 years) diagnosed according to the revised 1987 criteria of the American College of Rheumatology (formally, the American Rheumatism Association) [25]. All patients were receiving prednisolone (≤ 7.5 mg/day) and disease-modifying antirheumatic drugs. Clinical parameters in the study patients were as follows (mean ± standard deviation): erythrocyte sedimentation rate, 55.9 ± 35.4 mm/hour; serum C-reactive protein (CRP) level, 32.0 ± 32.0 mg/l; and IgM class rheumatoid factor titer, 142 ± 158 U/ml. Patients were divided into two groups: 24 patients with active disease, who had multiple tender and/or swollen joints and elevated serum CRP level (≥ 10 mg/l); and eight patients with inactive disease, who satisfied the American College of Rheumatology preliminary criteria for clinical remission [26]. Sixteen healthy volunteers (11 women and five men; age, 45.8 ± 11.2 years) served as controls. ST samples were obtained from three RA patients undergoing total knee replacement. All patients gave informed consent."}

ICD10

{"project":"ICD10","denotations":[{"id":"T6867","span":{"begin":271,"end":281},"obj":"http://purl.bioontology.org/ontology/ICD10/M79.0"}],"text":"Patients and samples\nThe total patient population consisted of 32 patients with RA (25 women and seven men; mean ± standard deviation age, 52.8 ± 12.4 years) diagnosed according to the revised 1987 criteria of the American College of Rheumatology (formally, the American Rheumatism Association) [25]. All patients were receiving prednisolone (≤ 7.5 mg/day) and disease-modifying antirheumatic drugs. Clinical parameters in the study patients were as follows (mean ± standard deviation): erythrocyte sedimentation rate, 55.9 ± 35.4 mm/hour; serum C-reactive protein (CRP) level, 32.0 ± 32.0 mg/l; and IgM class rheumatoid factor titer, 142 ± 158 U/ml. Patients were divided into two groups: 24 patients with active disease, who had multiple tender and/or swollen joints and elevated serum CRP level (≥ 10 mg/l); and eight patients with inactive disease, who satisfied the American College of Rheumatology preliminary criteria for clinical remission [26]. Sixteen healthy volunteers (11 women and five men; age, 45.8 ± 11.2 years) served as controls. ST samples were obtained from three RA patients undergoing total knee replacement. All patients gave informed consent."}

bionlp-st-ge-2016-test-ihmc

{"project":"bionlp-st-ge-2016-test-ihmc","denotations":[{"id":"T7311","span":{"begin":788,"end":791},"obj":"Protein"},{"id":"T7310","span":{"begin":361,"end":398},"obj":"Entity"},{"id":"T7309","span":{"begin":80,"end":82},"obj":"Protein"},{"id":"T7308","span":{"begin":566,"end":569},"obj":"Protein"},{"id":"T7307","span":{"begin":329,"end":356},"obj":"Entity"},{"id":"T7306","span":{"begin":610,"end":627},"obj":"Protein"},{"id":"T7305","span":{"begin":546,"end":570},"obj":"Protein"},{"id":"T7304","span":{"begin":487,"end":498},"obj":"Entity"},{"id":"T7303","span":{"begin":635,"end":646},"obj":"Entity"},{"id":"T7302","span":{"begin":1049,"end":1051},"obj":"Protein"},{"id":"T7301","span":{"begin":1085,"end":1087},"obj":"Protein"}],"text":"Patients and samples\nThe total patient population consisted of 32 patients with RA (25 women and seven men; mean ± standard deviation age, 52.8 ± 12.4 years) diagnosed according to the revised 1987 criteria of the American College of Rheumatology (formally, the American Rheumatism Association) [25]. All patients were receiving prednisolone (≤ 7.5 mg/day) and disease-modifying antirheumatic drugs. Clinical parameters in the study patients were as follows (mean ± standard deviation): erythrocyte sedimentation rate, 55.9 ± 35.4 mm/hour; serum C-reactive protein (CRP) level, 32.0 ± 32.0 mg/l; and IgM class rheumatoid factor titer, 142 ± 158 U/ml. Patients were divided into two groups: 24 patients with active disease, who had multiple tender and/or swollen joints and elevated serum CRP level (≥ 10 mg/l); and eight patients with inactive disease, who satisfied the American College of Rheumatology preliminary criteria for clinical remission [26]. Sixteen healthy volunteers (11 women and five men; age, 45.8 ± 11.2 years) served as controls. ST samples were obtained from three RA patients undergoing total knee replacement. All patients gave informed consent."}

bionlp-st-ge-2016-spacy-parsed

bionlp-st-ge-2016-test-tees

{"project":"bionlp-st-ge-2016-test-tees","denotations":[{"id":"T6872","span":{"begin":773,"end":781},"obj":"Positive_regulation"},{"id":"T6871","span":{"begin":782,"end":791},"obj":"Protein"},{"id":"T6870","span":{"begin":600,"end":603},"obj":"Protein"},{"id":"T6869","span":{"begin":566,"end":569},"obj":"Protein"},{"id":"T6868","span":{"begin":540,"end":564},"obj":"Protein"}],"relations":[{"id":"R3192","pred":"themeOf","subj":"T6871","obj":"T6872"}],"text":"Patients and samples\nThe total patient population consisted of 32 patients with RA (25 women and seven men; mean ± standard deviation age, 52.8 ± 12.4 years) diagnosed according to the revised 1987 criteria of the American College of Rheumatology (formally, the American Rheumatism Association) [25]. All patients were receiving prednisolone (≤ 7.5 mg/day) and disease-modifying antirheumatic drugs. Clinical parameters in the study patients were as follows (mean ± standard deviation): erythrocyte sedimentation rate, 55.9 ± 35.4 mm/hour; serum C-reactive protein (CRP) level, 32.0 ± 32.0 mg/l; and IgM class rheumatoid factor titer, 142 ± 158 U/ml. Patients were divided into two groups: 24 patients with active disease, who had multiple tender and/or swollen joints and elevated serum CRP level (≥ 10 mg/l); and eight patients with inactive disease, who satisfied the American College of Rheumatology preliminary criteria for clinical remission [26]. Sixteen healthy volunteers (11 women and five men; age, 45.8 ± 11.2 years) served as controls. ST samples were obtained from three RA patients undergoing total knee replacement. All patients gave informed consent."}

PMC:1064873 / 7035-8202 JSONTXT

Annnotations TAB JSON ListView MergeView

PMC:1064873 / 7035-8202 JSON TXT